TRAIL-Induced Keratinocyte Differentiation Requires Caspase Activation and p63 Expression  by Wu, Nan-Lin et al.
TRAIL-Induced Keratinocyte Differentiation Requires
Caspase Activation and p63 Expression
Nan-Lin Wu1,2,3, Te-An Lee4, Te-Lung Tsai5 and Wan-Wan Lin1
Cornification, the terminal differentiation of keratinocytes, is a special form of programmed cell death in the
skin. In this article, we report that tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) can induce
the expression of the keratinocyte differentiation markers involucrin and type 1 transglutaminase in normal
human epidermal keratinocytes. The induction of differentiation occurs mainly under the activation of caspases
3 and 8, and apoptosis can also be triggered. Inhibition of these apoptotic caspases attenuates both apoptosis
and differentiation of keratinocytes caused by TRAIL but barely affects the induction of differentiation caused
by calcium and phorbol 12-myristate 13-acetate. Differential regulation of extracellular signal–regulated kinase
and p38 activation by TRAIL is also observed. Moreover, the degradation of p63 is induced by TRAIL-elicited
caspase activation. However, the existence of p63 is essential for the initiation of keratinocyte differentiation by
TRAIL because knockdown of DNp63 decreases TRAIL-induced differentiation. Taken together, our results
suggest that TRAIL can be an inducer of both differentiation and apoptosis in human keratinocytes, and that
caspases critically mediate these processes. This study identifies a new role of apoptotic caspases for terminal
differentiation of keratinocytes and further elucidates the molecular pathways involved in this unique model of
cell death.
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INTRODUCTION
Cornification, a special model of programmed cell death, is
the result of terminal differentiation of keratinocytes and
plays a central role in cutaneous barrier formation (Candi
et al., 2005; Elias, 2005). Disturbance of this well-coordi-
nated process leads to a variety of skin diseases, including
skin cancers, ichthyosis, and psoriasis (Elias and Feingold,
2001; Candi et al., 2005; Descargues et al., 2008). In different
models of cell death in skin, apoptosis usually occurs in
proliferating keratinocytes (Lippens et al., 2005). Despite
previous confusion over the similarities and differences
between apoptosis and cornification, recent studies and the
latest recommendations of cell death classification indicate
that they occur through quite distinct molecular pathways
(Takahashi et al., 2000; Nickoloff et al., 2002; Lippens et al.,
2005; Kroemer et al., 2009). Cornification is a well-organized
and planned cell death characterized by the expression of
transglutaminases (TGases), loricrin, involucrin, and keratins
(Kroemer et al., 2009). During the terminal differentiation of
keratinocytes, dead cells are not eliminated but remain to
form the cornified barrier. p63 but not p53; TGases 1, 3, and
5, but not TGase 2; and caspase 14, but not apoptotic
caspases, are involved (Lippens et al., 2005). It has also been
proposed that apoptosis is blocked to avoid premature
apoptosis and to allow normal and complete cornification
(Polakowska and Haake, 1994; Nickoloff et al., 2002;
Allombert-Blaise et al., 2003; Weisfelner and Gottlieb,
2003; Raj et al., 2006).
Among the critical transcriptional factors involved in
keratinocyte differentiation, the importance of p63 has been
illustrated by p63/ mice that were reported to be born
dead without skin formation (Mills et al., 1999; Yang et al.,
1999). DNp63 isoforms are expressed mainly during the later
stages of epidermal morphogenesis and regulate the char-
acteristic genes expressed in proliferating keratinocytes
(Candi et al., 2006; Koster et al., 2007). In adult epidermal
keratinocytes, B99% of p63 transcripts were DNp63 iso-
forms. When epidermal keratinocytes exit proliferating status
and undergo terminal differentiation, the expression of
DNp63 is gradually downregulated (Truong and Khavari,
2007).
Tumor necrosis factor (TNF)–related apoptosis-inducing
ligand (TRAIL) is one of the members of the TNF superfamily.
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At least four types of human receptors specific for TRAIL have
been found: death receptor 4 (DR4), DR5, and decoy
receptors 1 and 2. DRs mediate TRAIL-induced apoptosis,
whereas decoy receptors may inhibit this death signaling
(Johnstone et al., 2008). The higher susceptibility of
transformed cells to TRAIL-induced apoptosis as compared
with normal cells has suggested the potential of TRAIL in
the treatment of various cancers, including skin cancers
(Nickoloff et al., 2002; Johnstone et al., 2008; Wang, 2008).
Likewise, primary normal human epidermal keratinocytes
(NHEKs) have also shown more resistance to TRAIL-induced
apoptosis than transformed keratinocyte cell lines (Leverkus
et al., 2000; Qin et al., 2001). Other than the death signaling
of TRAIL in skin, the physiological roles and regulation of
downstream signaling of TRAIL in normal epidermal kerati-
nocytes have been barely elucidated. In this study, we
investigated the effects of TRAIL on the differentiation of
primary cultured NHEKs and explored the underlying
molecular mechanisms. We found that at the concentrations
that induce apoptosis, TRAIL could also induce the expres-
sion of differentiation markers. Interestingly, caspases 3 and 8
participate in TRAIL-induced keratinocyte differentiation in
addition to their indispensable roles in TRAIL-induced
apoptosis.
RESULTS
TRAIL induces the expression of differentiation markers in
normal human epidermal keratinocytes
To explore the effects of TRAIL on keratinocyte differentia-
tion, we determined the expression of TGase 1, involucrin,
keratin 10, loricrin, and profilaggrin in NHEKs. As shown in
Figure 1a and b, TRAIL elicited the concentration-dependent
expression of TGase 1 and involucrin, which further
increased after prolonged treatment. Mild induction of other
differentiation markers, including keratin 10, loricrin, and
profilaggrin, could also be found, and prolonged treatment
seemed required for the expression of late markers (Figure 1b).
Given the expression of TRAIL receptors in the epidermis
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Figure 1. Induction of differentiation markers in NHEKs by TRAIL. (a) NHEKs were treated for 30 hours with TRAIL and assayed for the expression of
differentiation markers by immunoblotting. (b) NHEKs were treated with TRAIL (300 ngml1) for different periods. Expression of TGase 1, involucrin, keratin 10,
loricrin, and profilaggrin was determined. (c) Under different periods of culture in a high-calcium medium (1.5mM), the expression of TGase 1, involucrin, and
the receptors of TRAIL, including DR4, DR5, DcR1, and DcR2, was assayed by immunoblotting. (d) Cultured NHEKs were treated with TRAIL (300 ngml1) for
30 hours. Immunofluorescence staining was performed to detect the expression of involucrin and TGase 1 (green color). Nuclei were visualized by DAPI (blue).
DAPI, 40,6-diamidino-2-phenylindole; DcR, decoy receptor; DR, death receptor; NHEK, normal human epidermal keratinocyte; TGase, transglutaminase;
TRAIL, tumor necrosis factor–related apoptosis-inducing ligand. Bar¼ 50 mm.
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(Nickoloff et al., 2002), we sought to determine whether
TRAIL receptors are altered during keratinocyte differentia-
tion. Using calcium to induce differentiation for 3 days, we
observed no significant changes in TRAIL receptors (Figure
1c). In addition, we performed immunofluorescence staining
to confirm the TRAIL-induced expression of involucrin and
TGase 1 in NHEKs (Figure 1d).
Quantitative PCR also confirmed the concentration-
dependent induction of TGase 1 and involucrin mRNA by
TRAIL (Figure 2a). To assess the efficacy of TRAIL, we
compared its actions to those with calcium and phorbol 12-
myristate 13-acetate (PMA). Time-course experiments re-
vealed that within 24 hours of treatment, TRAIL increased the
expression of TGase 1 and involucrin mRNA to extents
similar to that with calcium (Figure 2b and c). Keratin 10
mRNA was slightly induced by TRAIL, whereas calcium
failed to exert this action (Figure 2d). The mRNA expression
of the late differentiation markers loricrin and profilaggrin
was also elevated by TRAIL, and their expression was either
sustained or further increased after 48 hours of treatment with
TRAIL (Figure 2e and f). Compared with the gene expression
responses of TRAIL and calcium for these keratinocyte
differentiation markers, we found that PMA displayed the
most prominent action (Figure 2). Taken together, our
observations of mRNA and protein expression demonstrated
that TRAIL can cause the expression of various differentiation
markers, especially TGase 1 and involucrin, within 24 hours
of incubation.
The activation of caspases 3 and 8 has a critical role in
TRAIL-induced apoptosis and differentiation
Next, to determine whether the classic apoptotic pathway
widely identified for TRAIL signaling, i.e., caspase activation,
is related to keratinocyte differentiation, we evaluated the
processing of caspases and cell viability of keratinocytes with
TRAIL and caspase inhibitor treatments. After treatment for
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Figure 2. TRAIL induces the mRNA expression of differentiation markers in NHEKs. (a) Under the treatment of TRAIL at different concentrations for 24 hours,
the changes of TGase 1 and involucrin mRNA in NHEKs were assayed. (b) After treatment with TRAIL (300 ngml1), high-calcium medium (1.5mM), or
PMA (50 nM), the time course of TGase 1 mRNA change was evaluated. Similar to panel b, time-dependent mRNA changes of (c) involucrin, (d) keratin 10,
(e) loricrin, and (f) profilaggrin were also examined. Real-time quantitative PCR analysis was performed to determine the mRNA changes of differentiation
markers. Student’s t-test was performed comparing the relative mRNA expression of those differentiation markers with untreated control cells. *Po0.05
(mean±SEM n¼ 3). NHEK, normal human epidermal keratinocyte; PMA, phorbol 12-myristate 13-acetate; TGase, transglutaminase; TRAIL, tumor necrosis
factor–related apoptosis-inducing ligand.
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2.5 hours, the dose-dependent cleavage of caspases 3 and 8
by TRAIL was detected (Figure 3a). Under pretreatment with
caspase 3 inhibitor (zDEVD-fmk, 10 mM) or caspase 8
inhibitor (zIETD-fmk, 10 mM), cell death (Figure 3b) and
processing of caspases 3 and 8 (Figure 3c) could be inhibited.
Strikingly, the differentiation markers induced by TRAIL were
also abrogated by inhibition of caspase 3 or 8 activation, but
those induced by PMA and calcium were not affected
significantly (Figure 3d). These data are consistent with the
current view that apoptotic caspases are not required for
common inducers of keratinocyte differentiation (Lippens
et al., 2000), but they point out the essential role of apoptotic
caspases with different inducers, such as TRAIL.
Regulation of ERK and p38 signaling by TRAIL requires caspase
3 and 8 activation
Given the critical roles of mitogen-activated protein kinase
(MAPK) signaling in keratinocyte differentiation (Gazel et al.,
2008; Ivanova et al., 2009), we sought to test for MAPK
signaling regulated by TRAIL in NHEKs. As shown in Figure
4a, the phosphorylation of p38 was elicited by TRAIL and
maintained for at least 3 hours, whereas the phosphorylation
of extracellular signal–regulated kinase (ERK)1/2 was inhib-
ited. The phosphorylation of c-Jun NH2-terminal kinase (JNK)
was barely affected (data not shown). The signaling of ERK1/2
and p38 affected by TRAIL gradually recovered at 7 hours
(Figure 4b). Because of the involvement of caspase 3 and 8
activation in TRAIL-induced differentiation (Figure 3d), we
used inhibitors of caspase 3 (zDEVD-fmk, 10 mM), caspase 8
(zIETD-fmk, 10 mM), and pan-caspase (zVAD-fmk, 10 mM) to
elucidate the relationship between caspase activation and
MAPK signaling. Figure 4c indicates that activation of p38 by
TRAIL was markedly diminished by each caspase inhibitor,
and that inhibition of ERK1/2 by TRAIL was also reversed. To
further address the roles of p38 in TRAIL-induced keratino-
cyte differentiation, we used SB203580 (3 mM) to suppress p38
activation, and it decreased the TGase 1 and involucrin
expression caused by TRAIL (Figure 4d). These results suggest
that the signals of MAPKs are very likely related to the
caspase activation caused by TRAIL in human keratinocytes,
and also provide evidence of a role for p38 in keratinocyte
differentiation.
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Figure 3. TRAIL-induced apoptosis and differentiation are mediated by caspase activation. (a) NHEKs were treated with TRAIL for 2.5 hours. The cell lysates
were subjected to immunoblotting to detect the cleavage of procaspases 3 and 8. Under the pretreatment of zDEVD-fmk (10 mM) or zIETD-fmk (10 mM) for
30minutes, (b) the cell death of NHEKs treated with TRAIL for 24 hours was measured by the MTT assay (*Po0.05, n¼ 3), (c) the cleavage of procaspases 3 and
8 in NHEKs with the treatment of TRAIL for 2.5 hours was evaluated by immunoblotting, and (d) NHEKs treated with TRAIL (upper panel), 1.5mM CaCl2, or PMA
(50 nM) (lower panel) for 30 hours were assayed for the expression of TGase 1 and involucrin by immunoblotting. MTT, 3-(4,5-dimethylthiazol-2-yl)2,5-
dephenyltetrazolium bromide; NHEK, normal human epidermal keratinocyte; PMA, phorbol 12-myristate 13-acetate; TRAIL, tumor necrosis factor–related
apoptosis-inducing ligand.
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Downregulation of p63 by TRAIL is mediated by the activation
of caspases but not by the decrease of mRNA
Given that a crucial role of p63 in keratinocyte terminal
differentiation has been identified (King and Weinberg,
2007), we also examined the change in p63 expression.
We observed concentration-dependent downregulation of
p63 expression induced by TRAIL (Figure 5a). However,
quantitative PCR revealed that p63 mRNA was unchanged
(Figure 5b). As compared with calcium, TRAIL could
gradually decrease p63 expression (Figure 5c). Therefore,
we tried to evaluate the effect of TRAIL on the course of p63
degradation and used the protein synthesis inhibitor cyclo-
heximide to avoid interference with new protein synthesis.
The results showed that the stability of the p63 protein and
the downregulation of p63 induced by TRAIL were enhanced
by the presence of cycloheximide (Figure 5d). Moreover,
by inhibiting caspase 3 and 8 activity, degradation of p63
by TRAIL could be attenuated (Figure 5d). Quantification
further confirmed the inhibitory effects of zDEVD-fmk
and zIETD-fmk on the degradation of p63 caused by
TRAIL (Figure 5d). These findings indicate that caspase
activation–mediated degradation of p63 may account for
the diminishment of p63 during TRAIL-induced keratinocyte
differentiation.
The existence of DNp63 is essential for TRAIL-induced
keratinocyte differentiation
Although DNp63 is downregulated during keratinocyte
terminal differentiation, it is crucial for the initiation of the
differentiation program (King and Weinberg, 2007; Koster
et al., 2007). To further explore the impact of DNp63 on the
action of TRAIL in apoptosis and differentiation of keratino-
cytes, we knocked down DNp63 using small-interfering RNA
(siRNA). The efficiency of the knockdown of DNp63 mRNA
and protein expression in NHEKs was confirmed (Figure 6a).
Under the knockdown of DNp63 isoforms, a mild increase in
the survival rate was detected by 3-(4,5-dimethylthiazol-2-
yl)2,5-dephenyltetrazolium bromide (MTT) assay (Figure 6b).
Figure 6c shows that the difference in cell death induced by
TRAIL was not significant statistically between the scramble
and DNp63 siRNA groups. In addition, DNp63 siRNA barely
affected the cleavage of caspase 3 induced by TRAIL, which
further confirmed the similar survival rates in these two
groups (Figure 6d). Quantitative PCR demonstrated that
DNp63 siRNA could attenuate TRAIL-induced TGase 1 and
involucrin mRNA, and immunoblotting further confirmed the
inhibitory effects of DNp63 siRNA (Figure 6e). In particular,
the inhibition of ERK1/2 phosphorylation and enhancement
of p38 phosphorylation by TRAIL could also be attenuated by
DNp63 siRNA (Figure 6f). Our results strongly suggest that
DNp63 is a prerequisite for the initiation of TRAIL-induced
differentiation, although the downregulation of DNp63
occurs during differentiation. Moreover, we demonstrate that
TRAIL-induced MAPK signaling in NHEKs is modulated by
DNp63.
DISCUSSION
A growing number of studies have pointed out the difference
between cornification and DR-mediated apoptosis (Gandarillas
et al., 1999; Lippens et al., 2000, 2005; Takahashi et al.,
2000), and the recent recommendation by the Nomenclature
Committee on Cell Death 2009 distinguished the cornifying
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Figure 4. Differential regulation of MAPK signaling by TRAIL in NHEKs. (a) NHEKs were treated with TRAIL (300 ngml1) for the indicated time points.
Immunoblotting with specific antibody against ERK1/2 or p38 was used to assess the activation of MAPK signaling. (b) Increasing the period of treatment, the
change of phosphorylated ERK1/2 and p38 elicited by TRAIL was also evaluated. (c) Under the pretreatment of zDEVD-fmk (10 mM), zIETD-fmk (10mM), or
zVAD-fmk (10 mM), NHEKs were treated with TRAIL for 3 hours. Cell lysates were then assayed by immunoblotting to evaluate the effects of caspase inhibition on
the TRAIL-induced signaling of ERK1/2 and p38. (d) Pretreatment of SB203580 (3 mM) was performed to examine the roles of p38 in TRAIL-induced keratinocyte
differentiation. ERK, extracellular signal-regulated kinase; MAPK, mitogen-activated protein kinase; NHEK, normal human epidermal keratinocyte; TRAIL, tumor
necrosis factor–related apoptosis-inducing ligand.
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process from apoptosis (Kroemer et al., 2009). In one study,
differentiating keratinocytes had less sensitivity to TRAIL-
induced apoptosis than did dividing keratinocytes, which
provides further evidence that keratinocyte differentiation is
distinct from DR-mediated apoptosis (Jansen et al., 2003). As
described to date, besides its widely explored roles in
epidermal keratinocyte death signaling (Leverkus et al.,
2000; Nickoloff et al., 2002; Diessenbacher et al., 2008),
TRAIL has not been shown to affect the expression of
differentiation markers in keratinocytes. However, another
member of the TNF superfamily, TNF-a, has been reported to
promote epidermal keratinocyte differentiation and regulate
cutaneous permeability barrier functions (Pillai et al., 1989;
Basile et al., 2001; Hatano et al., 2005). In fact, TRAIL was
demonstrated to induce differentiation of various cell types,
including intestinal cells and osteoclasts (Rimondi et al.,
2006; Yen et al., 2008); hence, we attempted to elucidate the
effects of TRAIL on keratinocyte differentiation and in fact
demonstrated the ability of TRAIL to promote the expression
of differentiation markers, especially TGase 1 and involucrin,
in cultured NHEKs. Nevertheless, despite the in vitro function
of TRAIL in the two-dimensional cultures revealed in our
study, skin lesions have never been mentioned in multiple
lines of reports using TRAIL/mice as models (Sedger et al.,
2002; Lamhamedi-Cherradi et al., 2003; Grosse-Wilde et al.,
2008). In these animal studies and other clinical investiga-
tions, the in vivo roles of TRAIL and/or TRAIL receptors were
mostly related to the processes of carcinogenesis and
immunological diseases and not to keratinocyte differentia-
tion (Cretney et al., 2002; Vassina et al., 2005; Eidsmo et al.,
2007). However, because the keratinocyte has been regarded
as a stress responder and undergoes differentiation in
response to barrier-breach stress (Wakabayashi et al., 2003;
Segre, 2006), possible roles of TRAIL in the barrier recovery
process after wounding in mouse models should be further
explored to evaluate other in vivo functions of TRAIL.
Many apoptotic and nonapoptotic caspases are expressed
in normal epidermal keratinocytes. Previous experiments
have indicated that the cleavage of apoptotic caspases is
barely detected during keratinocyte differentiation (Lippens
et al., 2000, 2005; Raymond et al., 2007). Nevertheless, the
involvement of apoptotic caspases such as caspase 3 in the
terminal differentiation of keratinocytes has been mentioned
(Allombert-Blaise et al., 2003; Okuyama et al., 2004;
Chaturvedi et al., 2006). In addition, a recent investigation
demonstrated that the loss of epidermal caspase 8 leads to
epidermal hyperplasia (Lee et al., 2009), and accumulation of
death effector domains of caspase 8 was observed during
keratinocyte differentiation (Mielgo et al., 2009). In the
present study, we found that induction of differentiation
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markers by TRAIL could be abolished via the inhibition of
caspase 3 and 8 activities but that PMA- and calcium-
induced differentiation was barely affected. It was foresee-
able that PMA- and calcium-induced differentiation would be
insensitive to caspase inhibitors because calcium has been
believed to regulate keratinocyte differentiation through
multiple distinct interacting pathways (Ng et al., 2000; Bikle
et al., 2004), and protein kinase C activation by calcium and
PMA was critically required for TGase expression (Dlugosz
and Yuspa, 1994; Bikle et al., 2004). This suggests that
apoptotic caspases 3 and 8 may mediate, in particular,
TRAIL-induced keratinocyte differentiation. It is noteworthy
1.2
1.0
0.8
0.6
0.4
0.2
0.0
160
140 *
120
100
80
60
40
20
0
120
100
80
60
Su
rv
iva
l r
a
te
 (%
 fo
 c
o
n
tro
l)
Fo
ld
 o
f m
RN
A 
ch
an
ge
 
40
20
0
0 30 100 300
TRAIL (ng ml–1)
Scramble
siRNA
Scramble siRNA Involucrin
TGase 1
*
*
Scramble
siRNA
ΔNp63
siRNA
ΔN
p6
3
siR
NASc
ram
ble
siR
NA
– + – +
ΔNp63
siRNA
Scramble siRNA
0
p-ERK 1/2
ERK2
p-p38
p38
p63
15 30 3015060 6018
0
18
0 36
0 (minutes)
ΔNp63 siRNA
ΔNp63 siRNA
ΔN
p6
3
siR
NA
TRAIL (300 ng ml–1)
Procaspase 3
Cleaved caspase 3
*
Sc
ram
ble
siR
NA ΔN
p6
3
siR
NASc
ram
ble
siR
NA
– –+ +
Fo
ld
 o
f Δ
N
p6
3 
m
RN
A
ch
an
ge
R
el
at
ive
 v
a
lu
e 
of
 M
TT
(%
 of
 co
ntr
ol)
Actin
TRAIL (300 ng ml–1)
Involucrin
TGase 1
p63
Actin
7
6
5
4
3
2
1
0
TRAIL
(300 ng ml–1)
– +
Scramble siRNA ΔNp63 siRNA
+–
36
0
Figure 6. Knockdown of DNp63 decreases TRAIL-induced differentiation but barely affects TRAIL-induced cell death. (a) Real-time quantitative PCR and
immunoblotting confirmed the knockdown of DNp63. (b) The MTT assay determined the survival of NHEKs with DNp63 siRNA for 72 hours and (c) NHEKs with
TRAIL treatment for an additional 24 hours after knockdown of DNp63 for 48 hours. (d) Immunoblotting examined the effect of DNp63 siRNA on the TRAIL-
elicited cleavage of procaspase 3. (e) The effects of DNp63 siRNA on the TRAIL-induced expression of mRNA and protein of involucrin and TGase 1. (f) MAPK
signaling in NHEKs treated with TRAIL (300 ngml1) after knockdown of DNp63 for 48 hours *Po0.05 versus scramble siRNA (mean±SEM n¼3). MAPK,
mitogen-activated protein kinase; MTT, 3-(4,5-dimethylthiazol-2-yl)2,5-dephenyltetrazolium bromide; NHEK, normal human epidermal keratinocyte; siRNA,
small-interfering RNA; TRAIL, tumor necrosis factor–related apoptosis-inducing ligand.
880 Journal of Investigative Dermatology (2011), Volume 131
N-L Wu et al.
Caspase Activation in Keratinocyte Differentiation
that apoptosis is also induced by TRAIL at high concentra-
tions, as reported previously (Leverkus et al., 2000; Jansen
et al., 2003). We were not surprised by this phenomenon
because various studies have revealed that many inducers,
such as sulfur mustard, betulinic acid, and okadaic acid, can
also cause apoptosis in addition to inducing keratinocyte
differentiation (Rosenthal et al., 1998; Efimova et al., 2003;
Galgon et al., 2005; Kraft et al., 2007). Taken together, our
results indicate that TRAIL can be an inducer of both
differentiation and apoptosis in normal human keratinocytes.
MAPK pathways are differentially involved during kerati-
nocyte differentiation. Regulatory roles of JNK and ERK in
response to different inducers of keratinocyte differentiation
have been demonstrated (Schmidt et al., 2000; Efimova et al.,
2003; Gazel et al., 2006, 2008). As for p38, different isoforms
might differentially regulate keratinocyte differentiation
stimulated by distinct agents (Eckert et al., 2003; Efimova
et al., 2003; Ivanova et al., 2009). In our study, TRAIL could
obviously activate p38 and inactivate ERK, whereas JNK
activity was barely affected. Inhibition of p38a/b activity by
SB203580 could partially diminish the expression of differ-
entiation markers. Interestingly, caspase inhibition reversed
TRAIL-regulated MAPK signaling. This phenomenon is similar
to the finding in a recent report that TRAIL-induced MAPK
signaling was dependent on caspase activation and required
the mammalian sterile 20-like kinase 1 as a mediator (Song
and Lee, 2008). This means that TRAIL-induced MAPK
signaling in keratinocytes can be downstream of caspase
activation.
Repression of DNp63 expression is critical for controlling
the proliferation and differentiation of keratinocytes (King and
Weinberg, 2007; Yi et al., 2008). In our study, the
concentration- and time-dependent decrease in p63 expres-
sion by TRAIL was through caspase-dependent degradation
but not attributable to DNp63 mRNA expression. In fact, p63
has been shown to be degraded by caspase activation under
the overexpression of p53 (Ratovitski et al., 2001) and
stimulation with TNF-a (Lee et al., 2007). Given the roles of
DNp63 in tumorigenesis (King andWeinberg, 2007; Sabbisetti
et al., 2009), degradation of p63 by TRAIL may further show
the potential of TRAIL in the treatment of cancers.
Using a mouse model with an epidermal-specific knock-
down of DNp63 and regenerating the human epidermis with
knockdown ofDNp63, DNp63 was shown to be essential for
not only the proliferative potential but also the initiation of
terminal differentiation in developmentally mature keratino-
cytes (Truong et al., 2006; Koster et al., 2007). In this study,
we demonstrated that knockdown of DNp63 in keratinocytes
would attenuate TRAIL-induced differentiation markers. This
means that, despite diminution of DNp63 by TRAIL, DNp63 is
essential for the induction of differentiation by TRAIL. In
addition, we showed that ERK1/2 and p38 signaling changed
by TRAIL can be partially reversed via knockdown of DNp63,
revealing the unique role of DNp63 in TRAIL-evoked
signaling.
In summary, we demonstrate that TRAIL can be an inducer
of both differentiation and apoptosis of NHEKs. Activation of
apoptotic caspases is a prerequisite for TRAIL-induced
differentiation and also modulates TRAIL-activated MAPK
pathways in keratinocytes. Furthermore, despite the caspase-
mediated degradation of p63, DNp63 is essential for the
initiation of TRAIL-induced differentiation and MAPK signal-
ing. These findings provide insights into the molecular
mechanisms of keratinocyte terminal differentiation regulated
by an apoptosis inducer and apoptotic caspases, and they
also reveal another beneficial effect of TRAIL in the therapy of
skin cancers.
MATERIALS AND METHODS
Cell culture
NHEKs were obtained from normal adult human foreskin. In brief,
the skin was divided and incubated in 1% protease (Sigma-Aldrich,
St Louis, MO) overnight at 4 1C. After the epidermis was separated
from the dermis, the keratinocytes were disaggregated into a single-
cell suspension in serum-free DMEM and then centrifuged. The
keratinocytes were cultured in Keratinocyte-SFM (Gibco BRL/
Invitrogen, Carlsbad, CA) supplemented with recombinant epider-
mal growth factor (0.1–0.2 ngml1), bovine pituitary extract
(20–30 mgml1), and 1% penicillin/streptomycin in a humidified
atmosphere at 37 1C and 5% CO2. The second- to fourth-passage
cells were used in the experiments. The experiments were conducted
according to the Declaration of Helsinki Principles and approved by
the ethics committee of Mackay Memorial Hospital. Written consent
was obtained from each donor before the experiments were
performed.
Reagents
Antibodies directed against JNK1, ERK2, p38, TGase 1, involucrin,
and horseradish peroxidase–coupled secondary antibodies were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
Antibodies for human keratin 10, loricrin, and filaggrin were
purchased from Covance (Emeryville, CA). Antibodies for caspase
3, caspase 8, phosphorylated-JNK, phosphorylated-ERK, and phos-
phorylated-p38 were purchased from Cell Signaling Technology
(Beverly, MA). Antibody against b-actin was obtained from Upstate
Biotechnology (Charlottesville, VA). The enhanced chemilumines-
cence reagent was purchased from PerkinElmer (Wellesley, MA).
Soluble recombinant human TRAIL was purchased from PeproTech
(Rocky Hill, NJ). Caspase inhibitors (zVAD-fmk, zDEVD-fmk, zIETD-
fmk) were purchased from Calbiochem (San Diego, CA).
Measurement of cell viability by MTT assay
The indicated drugs were added to cells plated in 24-well plates for
24 hours. Cell viability was measured by the MTT assay as described
previously (Su et al., 2008).
Immunoblotting
After treatments with the indicated drugs, cells were harvested and
equal amounts of the soluble protein were loaded and electrophor-
esed on 6–10% SDS-PAGE, and then transferred to Immobilon-P
(Millipore, Billerica, MA). Specific protein bands were detected
using the enhanced chemiluminescence detection reagent.
Real-time PCR
After stimulation, cells were harvested and subjected to reverse
transcription using a real-time-PCR kit (Promega, Heidelberg,
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Germany) as described previously (Lin et al., 2010). PCR was
performed in 96-well plates using FastStart SYBR Green Master
(Roche Diagnostics, Indianapolis, IN) and determined using ABI
Prism 7900 (Applied Biosystems, Oakland, CA). The level of mRNA
expression was analyzed by normalizing to the housekeeping gene
cyclophilin A. Primers used are listed in Supplementary Materials
and Methods online (Supplementary Table S1 online).
Small-interfering RNA
Small-interfering RNA targeting mRNA degradation of human
DNp63 isoforms (GGACAGCAGCATTGATCAA) and scramble non-
specific siRNA (CAGTCGCGTTTGCGACTGG) were purchased from
Dharmacon Research (Lafayette, CO). NHEKs were transfected with
100 nM siRNA using DharmaFECT transfection reagents at 50%
confluence following the manufacturer’s instructions. Cells were
treated with the indicated drugs 48 hours after transfection.
Immunofluorescence
NHEKs were fixed with 4% paraformaldehyde in phosphate-buffered
saline. After two washes with phosphate-buffered saline, the fixed
cells were incubated in 4% milk containing 0.1% Triton-X 100.
Next, cells were incubated with primary antibodies against human
involucrin and TGase 1 at 4 1C overnight. After being washed, cells
were incubated with fluorescein isothiocyanate–labeled secondary
antibodies and nuclei were visualized with 40,6-diamidino-2-
phenylindole.
Statistical evaluation
Data were expressed as mean±SEM, and Student’s t-test was used to
assess the statistical significance of the differences. A P-valueo0.05
was considered statistically significant.
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